Direct-to-Consumer (DTC) Genetic Testing Business Report 2023-2030 with Focus on 80+ Players Including 23andMe, Ancestry.com, Chengdu 23Mofang Biotechnology, and DirectLabs
August 07, 2024 09:32 ET
|
Research and Markets
Dublin, Aug. 07, 2024 (GLOBE NEWSWIRE) -- The "Direct-to-Consumer (DTC) Genetic Testing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global...
Hereditary Genetic Testing Research 2024: An $81.95 Billion Market by 2033 - A Rapidly Evolving Landscape Fuelled by Strategic Collaborations and Innovative Advancements
August 07, 2024 05:19 ET
|
Research and Markets
Dublin, Aug. 07, 2024 (GLOBE NEWSWIRE) -- The "Global Hereditary Genetic Testing Market: Focus on Product, Sample Type, Technology, Genetic Testing Type, Application Area, Region, and Competitive...
Baylor Genetics and Baylor College of Medicine Announce New Lab Agreement with Shared Commitment to Innovation and Rapid Implementation to get Critical Testing to Patients
August 05, 2024 10:00 ET
|
Baylor Genetics
Baylor Genetics and the Department of Molecular and Human Genetics at Baylor College of Medicine have entered a new lab agreement.
Interpace Diagnostics® Announces Undefined Extension of Medicare Coverage for PancraGEN®, a Molecular Diagnostic Test That Assesses Cancer Risk of Pancreatic Cysts
July 29, 2024 08:25 ET
|
Interpace Biosciences, Inc.
PARSIPPANY, NJ, July 29, 2024 (GLOBE NEWSWIRE) -- Interpace Diagnostics®, a subsidiary of Interpace Biosciences®, (“Interpace” or the “Company”) (OTCQX: IDXG) today responded to the undefined...
Global Genetic Toxicology Testing Market Report 2024: Projected to Generate $4.56 Billion in Revenue by 2031, with Cloud and SaaS Platforms Becoming Essential for Market Competitiveness
June 25, 2024 09:26 ET
|
Research and Markets
Dublin, June 25, 2024 (GLOBE NEWSWIRE) -- The "Genetic Toxicology Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade,...
Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27
June 21, 2024 08:00 ET
|
Genetic Technologies Ltd
Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27
Genetic Technologies Expands Operational Capacity in North America
June 18, 2024 08:00 ET
|
Genetic Technologies Ltd
GeneType Expands Operational Capacity in North America
GTG Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian Cancer
May 29, 2024 08:00 ET
|
Genetic Technologies Ltd
Genetic Technologies Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian Cancer
Myriad Genetics Showcases New Research and Product Innovations Advancing Cancer Care at 2024 ASCO® Annual Meeting
May 23, 2024 18:00 ET
|
Myriad Genetics, Inc.
SALT LAKE CITY, May 23, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and its collaborators will share data from seven studies...
Baylor Genetics Launches RNASeq Test for Whole Genome and Whole Exome Sequencing, Reduces Turnaround Times, Introduces Four New Genetic Analysis Panels
May 13, 2024 09:00 ET
|
Baylor Genetics
Baylor Genetics today announced the availability of a new RNA sequencing test, RNAseq, for Whole Exome and Whole Genome Sequencing (WES/WGS).